FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/09/2023
Back to search
Official data from USPTO
NANOBIOTIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/09/2023
Classification
Registered
Trademark type
Combined
Nice classes
5, 10
Filing date
03/31/2021
Registration date
09/13/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2022
Last transaction
09/13/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
FR
Examiner
CROWDER-SCHAEFER, ANDREW W
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
"NANOBIOTIX" in black capital letters with the letter "X" stretched.
Holders and representatives
Holders
Nanobiotix
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspreparations for medical use particularly for tumor diagnosis and treatment; pharmaceutical productspreparations for medical useespecially for the diagnosis and treatment of tumors using radiotherapy; radioactive productssubstances for medical useespecially for the diagnosis and treatment of tumors using radiotherapy; health productspharmaceutical productsfor the treatment of tumors; radiological contrast substances for medical use; chemical reagents for medical use; chemical preparations for medical or pharmaceutical usefor the treatment of tumors; diagnostic products for medical usemedicines for the treatment of tumors; drugs for medical usepharmaceutical products for use in the treatment of cancer; medicines for human medicinepharmaceutical products for the treatment of tumors; chemicopharmaceutical products for use in treating oncological diseases and disorders; pharmaceutical products for use in treating oncological diseases and disorders
Class 10
Surgical and medical apparatus and instrumentsradiotherapy apparatus especially for the diagnosis and treatment of tumors using radiotherapy; radiotherapy apparatus; testing apparatus for medical usefor testing tumor characteristics; diagnosis apparatus for medical usefor testing tumor characteristics; radiological apparatus for medical use; apparatus and installations for the production of X-Rays for medical use
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/15/2022
FIMP
FINAL DISPOSITION PROCESSED
12/15/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/13/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2022
RFNT
REFUSAL PROCESSED BY IB
01/10/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/21/2021
RFRR
REFUSAL PROCESSED BY MPU
12/21/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/19/2021
CNRT
NON-FINAL ACTION WRITTEN
11/18/2021
DOCK
ASSIGNED TO EXAMINER
11/15/2021
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
10/05/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/19/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/18/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/24/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/20/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/15/2021
Continuous trademark protection
Get notified about every new filing that threatens NANOBIOTIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.